Healshape
PrivateLast Round
Seed
Jun 28, 2022
Total Funding Raised
$6.3M
Company Overview
Healshape operates in Healthcare & Life Sciences and is based in Lyon. Its latest recorded funding round was a Seed round in June 2022.
Healshape is a regenerative medicine company that develops 3D-bioprinted, personalized, and resorbable bioprostheses for soft tissue reconstruction.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, 3D Printing, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Healshape Comparables
Compare Healshape with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lattice Medical | 88% | |
| GenesisTissue Inc. | 88% | |
| BellaSeno | 87% |
For institutional investors. Book with your work email.
Healshape Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 28, 2022 | ||||
| Grant | Jul 16, 2020 | ||||
| Accelerator | Jan 28, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Healshape Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Les Premières Auvergne-Rhône-Alpes | Accelerator |
| GO Capital | Seed |
| Angels Santé | Seed |
| Pulsalys | Accelerator |
| WinEquity | Seed |
| Crédit Agricole Création | Seed |
| Bpifrance | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 5, 2024
Grew 17% QoQ, from 18 to 21 employees.
- Jun 28, 2022
$6.3M round led by Demea Sustainable Investment and GO Capital.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingNov 5, 2026
Healshape is developing a porous, bio-based hydrogel bioprosthesis that acts as a temporary scaffold for breast tissue regeneration; after completing preclinical phases, it schedules human trials for H1 '27 in France.
- recognized_asOct 29, 2026
Healshape is one of the winners of La French Tech's first French Tech Health20 programme, which supports high-potential start-ups and develops solutions for health, technological and industrial challenges, on Oct 29th '26.
For institutional investors. Book with your work email.
Healshape Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Healshape's valuation, stock price, and market status.
Is Healshape a public or private company?
Healshape is a private company.
What is the current stock price of Healshape?
Healshape is a private company, so its shares have no public market price. Caplight tracks Healshape's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Healshape worth (valuation)?
Valuation information for Healshape is not publicly available.
Can I buy Healshape stock?
Healshape shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Healshape's last funding round?
Healshape's most recent funding round was Seed on June 28, 2022.
Who are the main investors in Healshape?
Key investors in Healshape include GO Capital, Pulsalys, Demea Sustainable Investment.
Will Healshape IPO soon?
No public IPO plans have been announced for Healshape.
How can I track Healshape secondary market activity?
Caplight tracks bids, offers, and trades in Healshape's shares on secondary markets.